comparemela.com
  1. Home
  2. Live Updates
  3. Talquetamab Talvey - Breaking News

Latest Breaking News On - Talquetamab talvey - Page 1 : comparemela.com

Talquetamab Dose Modifications May Lower AEs While Maintaining Efficacy in R/R Multiple Myeloma

Dose modifications of talquetamab improved on-target adverse effects while maintaining responses for patients with relapsed/refractory multiple myeloma.

United statesSan franciscoTalquetamab talveyHelen diller family comprehensive cancer centerAmerican society of hematology annual meetingUniversity of californiaMyeloma programHematology annualAjai chariMultiple myeloma programDiller family comprehensive cancer

Talquetamab Dose Modifications May Lower AEs While Maintaining Efficacy in R/R Multiple Myeloma

Dose modifications of talquetamab improved on-target adverse effects while maintaining responses for patients with relapsed/refractory multiple myeloma.

San franciscoUnited statesTalquetamab talveyHelen diller family comprehensive cancer centerMyeloma programUniversity of californiaAjai chariMultiple myeloma programDiller family comprehensive cancerGprc5d cd3 bispecific antibodyPhase 1 2 monumental studiesRelapsed refractory multiple myeloma2023 ash annual meetingAdverse effects

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.